Outcome of Board Meeting

209/LG/SE/JULY/2026/GBSL July 31, 2026 To To BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, Bandra Kurla Complex, Dalal Street, Fort, Mumbai – 400 001 Bandra (E), Mumbai – 400 051 Scrip Code : 509079 Scrip Symbol : GUFICBIO Subject: Outcome of the Board of Directors Meeting held on Friday, July 31, 2026 Dear Sir/Madam, Pursuant to Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’), we wish to inform that the Board of Directors of the Company at its meeting held today, i.e. July 31, 2026, has, inter-alia, considered and approved the Re-appointment of Mr. Pankaj Jayakumar Gandhi (DIN: 00001858) as the Whole Time Director of the Company, liable to retire by rotation, for a further term of 5 (five) years with effect from September 07, 2026 to September 06, 2031 (both days inclusive), subject to approval of the shareholders at the ensuing 42nd Annual General Meeting of the Company. Further, it is hereby confirmed that Mr. Pankaj Jayakumar Gandhi is not debarred from holding the office of Director by virtue of any order passed by Securities and Exchange Board of India (SEBI) or any other such authority. The details as required under Regulation 30 of SEBI Listing Regulations read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 is enclosed as Annexure A. The meeting of the Board of Directors commenced at 04:30 p.m. and concluded at 06:25 p.m. Kindly take the same on your record. Thanking You, Yours truly, For Gufic Biosciences Limited Ami Shah Company Secretary & Compliance Officer Membership No. A39579 Encl.: As above Annexure A Particulars Details Reason for change Re-appointment of Mr. Pankaj Jayakumar Gandhi (DIN : 00001858) as a Whole Time Director Date of appointment/ cessation Re-appointment with effect from September 07, 2026 Term of appointment/ re-appointment Re-appointment of Mr. Pankaj Gandhi as a Whole Time Director of the Company for a further term of 5 years with effect from September 07, 2026 to September 06, 2031 (both days inclusive), subject to approval of the shareholders in the ensuing 42nd Annual General Meeting of the Company. Brief profile (in case of appointment) Mr. Pankaj Gandhi holds a Bachelor’s degree in Commerce from the University of Mumbai and brings with him over three decades of rich and extensive experience in liaising with regulatory authorities within the pharmaceutical industry. He has played a key role in ensuring regulatory compliance and maintaining effective co-ordination with various statutory and regulatory authorities. His expertise and extensive experience have contributed significantly to the smooth functioning and operational efficiency of the Company. Disclosure of relationships between Mr. Pankaj Gandhi is not related to any Directors of the directors (in case of appointment of Company. director)